Skip to main content
. 2022 Jun 27;11(11):e024214. doi: 10.1161/JAHA.121.024214

Figure 2. Primary composite end point and cumulative incidence of stroke stratified by EAST‐AFNET 4 (Early treatment of atrial fibrillation for stroke prevention trial) eligibility criteria.

Figure 2

Cumulative incidence curves for the primary outcome, a composite of all‐cause mortality, stroke, or hospitalization with the diagnoses of heart failure or myocardial infarction in the early rhythm‐control group (red) or control group (blue), stratified by EAST‐AFNET 4 trial eligibility criteria. Overall cohort (A and B), patients who would be potentially eligible for EAST‐AFNET 4 (C and D), and patients who would be ineligible for EAST‐AFNET 4 (E and F). The control group was the reference group in the Cox proportional hazards regression analyses. All of the curves and numbers were calculated using propensity score weighting. *To maintain deidentification, OptumLabs does not allow researchers to disclose the number of events when the number is ≤10. HR indicates hazard ratio.